Genentech is Broadway bound with latest campaign to raise spinal muscular atrophy awareness

Genentech is taking its spinal muscular atrophy awareness efforts to New York with an original musical comedy. The show, called “Most Likely Not To…” will be performed on Feb. 29, also known as Rare Disease Day, with a cast that includes actors, writers and performers with SMA.

Created in consultation…
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks